Etiology of Hormone Receptor Positive Breast Cancer Differs by Levels of Histologic Grade and Proliferation

International Journal of Cancer - United States
doi 10.1002/ijc.31352
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Progesterone Receptor Expression in Proliferating Cancer Cells of Hormone-Receptor-Positive Breast Cancer

Tumor Biology
MedicineCancer Research
2018English

Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer

Geburtshilfe und Frauenheilkunde
GynecologyMidwiferyMaternityObstetrics
2019English

Prevention of Breast Cancer by Recapitulation of Pregnancy Hormone Levels

Breast Cancer Research
Cancer ResearchOncology
2003English

Factors Determining Anthracycline Use in Hormone Receptor Positive, Early Stage Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2019English

Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2003English

The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy

Clinical Cancer Research
Cancer ResearchOncology
2019English

Folate Intake and Risk of Breast Cancer Characterized by Hormone Receptor Status

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2005English

CpG Promoter Hypo-Methylation and Up-Regulation of microRNA-190b in Hormone Receptor-Positive Breast Cancer

Oncotarget
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy